Detailed Narrative
Strong Q1 FY26 Financial Performance
QMS Medical Allied Services reported its highest-ever Q1 revenue of ₹46.5 crores, marking a substantial 53% year-on-year growth. This robust top-line performance translated into significant profit expansion, with EBITDA increasing by 36.56% to ₹6.76 crores and Profit After Tax (PAT) growing by 31.25% to ₹3.15 crores. These results indicate the company's effective strategy in capitalizing on India's pharma promotion sector potential.
Exceptional Growth in Q-Devices Segment
The company's own brand, Q-Devices, demonstrated remarkable performance by achieving ₹10 crores in revenue during Q1 FY26 alone. This figure surpasses the entire revenue generated by Q-Devices in the previous fiscal year (FY25), highlighting accelerated market penetration and acceptance. The growth is attributed to the introduction of new products, increased brand awareness, and successful engagement with institutional clients in the B2B space.
Services Business Expansion and Saarathi Integration
The services business, including the acquired Saarathi, contributed ₹11 crores to the Q1 FY26 revenue. Post-acquisition, the combined services program revenue has grown 1.5 times in just two years, solidifying QMS's leadership in the B2B pharma promotion sector. Saarathi, a pioneer in patient service programs, reported ₹4.6 crores in revenue and approximately ₹50 lakhs in profit for Q1 FY26. The company plans to acquire the remaining 49% stake in Saarathi in tranches by September 2026, valuing it at 7x EBITDA.
Strategic Focus on Pharma Promotion Market
Management characterized the Indian pharma promotion market as a highly unregulated and fragmented sector, estimated to be worth ₹10,000-₹12,000 crores. QMS positions itself as one of the few players with a turnover exceeding ₹100 crores in this segment. The company is actively exploring new opportunities in non-pharma domains for its patient service programs and CAMs business, alongside pursuing inorganic growth opportunities in the B2B space.
Humrahi Program: A Key Contributor
The Humrahi program, a patient service initiative, is provided free of charge to patients, with QMS acting as a paid facilitator and coordinator. This program operates on an 80% fixed and 20% variable fee structure and contributes approximately 6-7% of the company's total turnover. It underscores QMS's commitment to patient services while generating a stable revenue stream.